Medical experts discuss a specific case for a patient diagnosed with stage IIIB NSCLC.
Back
Updates in the Management of Stage III Non-Small Cell Lung Cancer (NSCLC)
Led by Sandip P. Patel, MD, key opinion leaders address key updates in treatment strategies and management of stage III NSCLC.
Updates in the Management of Stage III Non-Small Cell Lung Cancer (NSCLC)
Episodes
All
All
Panelists discuss the utilization of testing and multidisciplinary approaches for testing.
The panel discusses a variety of clinical trials and the impact on patient treatment in early stage NSCLC.
A variety of treatment options in ES NSCLC are explored by key opinion leaders.
The panel discusses reassessing for respectability after certain treatments.
The panel discusses management of resectable early-stage non–small cell lung cancer.
The panel discusses the factors that go into selecting patients for adjuvant therapy.
The panel looks at a second patient case study.
The panel discusses data necessary for selecting patients with unrespectable non–small cell lung cancer for sequential vs concurrent chemoradiotherapy.
The panel discusses treatment considerations for consolidation durvalumab.
Advertisement
Advertisement
Trending on OncLive
1
Phase 3 eVOLVE-Lung02 Trial of First-Line Volrustomig Is Discontinued in First-Line Metastatic NSCLC
2
T-DXd Improves PFS in First-Line HER2-Mutant NSCLC
3
FDA Grants Fast Track Designation to Sapanisertib and Serabelisib Plus Paclitaxel in Advanced Endometrial Cancer
4
Dr Viansone on ADC Sequencing in Metastatic HER2+ Breast Cancer
5